As an innovative company with great ambition to develop value-added medicines and treatment options that benefit patients, we are incredibly proud to be accepted as a full member of the British Generic Manufacturers Association (BGMA). The BGMA represents the interests of UK-based manufacturers and suppliers of generic medicines and promotes the development of the generic medicines industry in the UK.
Andy Trouton, Managing Director of Colonis, said: “We’re delighted to become full members of the BGMA and look forward to contributing to the activities and workstreams of the association. We see this as an important next step for Colonis as we continue to grow and become more active in the generic medicines community. We are incredibly proud to be accepted as a member of an association that represents and promotes the interests of UK-based manufacturers and suppliers.“
Mark Samuels, Chief Executive of the British Generic Manufacturers Association (BGMA), said: “We are very pleased to have added Colonis to our membership and look forward to their contributions and support in our work representing the off-patent sector, which delivers four out of five prescription medicines to NHS patients.”